IVZ vs. BEN: Which Stock Should Value Investors Buy Now? — Positive

BEN  IVZ   Zacks Investment Research — July 14, 2025

Investors interested in Financial - Investment Management stocks are likely familiar with Invesco (IVZ) and Franklin Resources (BEN). But which of these two stocks presents investors with the better value opportunity right now?

image for news IVZ vs. BEN: Which Stock Should Value Investors Buy Now?

VIRT vs. MCO: Which Stock Is the Better Value Option? — Positive

MCO  VIRT   Zacks Investment Research — July 14, 2025

Investors with an interest in Financial - Miscellaneous Services stocks have likely encountered both Virtu Financial (VIRT) and Moody's (MCO). But which of these two stocks is more attractive to value investors?

image for news VIRT vs. MCO: Which Stock Is the Better Value Option?

VWDRY vs. ETN: Which Stock Should Value Investors Buy Now? — Positive

ETN  VWDRY   Zacks Investment Research — July 14, 2025

Investors interested in Manufacturing - Electronics stocks are likely familiar with Vestas Wind Systems AS (VWDRY) and Eaton (ETN). But which of these two stocks presents investors with the better value opportunity right now?

image for news VWDRY vs. ETN: Which Stock Should Value Investors Buy Now?

HDLMY vs. ROAD: Which Stock Is the Better Value Option? — Positive

ROAD   Zacks Investment Research — July 14, 2025

Investors with an interest in Building Products - Miscellaneous stocks have likely encountered both Heidelberg Materials AG Unsponsored ADR (HDLMY) and Construction Partners (ROAD). But which of these two stocks presents investors with the better value opportunity right now?

image for news HDLMY vs. ROAD: Which Stock Is the Better Value Option?

MONSEY, N.Y., July 14, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Monogram Technologies, Inc. (Nasdaq: MGRM) (“Monogram”) to Zimmer Biomet for an upfront payment of $4.04 per share in cash, and a non-tradeable contingent value right (CVR) entitling the holder to receive up to $12.37 per share in cash if certain product development, regulatory, and revenue milestones are achieved through 2030.

image for news MGRM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Monogram Technologies to Zimmer Biomet

Gold, silver see routine profit-taking pressure — Neutral

AAAU  BAR  DBP  DGL  GLD  GLDM  IAU  OUNZ  SGOL  SIL  SILJ  SIVR  SLV  SLVP  UGL   Kitco — July 14, 2025

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

image for news Gold, silver see routine profit-taking pressure

FDA Rejects CAPR's Cell Therapy BLA for Genetic Disorder, Stock Tanks — Negative

CAPR   Zacks Investment Research — July 14, 2025

Capricor slumps 33% as the FDA rejects its BLA for DMD drug, deramiocel, citing lack of effectiveness data and CMC issues.

image for news FDA Rejects CAPR's Cell Therapy BLA for Genetic Disorder, Stock Tanks

Autodesk signals it will no longer pursue PTC acquisition, shares rise — Positive

ADSK   Proactive Investors — July 14, 2025

Autodesk Inc (NASDAQ:ADSK) shares gained almost 6% on Monday after the company signalled it has dropped its pursuit of acquiring PTC Inc (NASDAQ:PTC), a fellow engineering software firm valued at about $23 billion. In a filing with the Securities and Exchange Commission (SEC), Autodesk said it will be focused on its strategic priorities, indicating there will be no deal with PTC without mentioning the Boston-based firm by name.

image for news Autodesk signals it will no longer pursue PTC acquisition, shares rise

OXY Stock is Trading Above 50-Day SMA: Time to Buy, Hold or Sell? — Positive

OXY   Zacks Investment Research — July 14, 2025

OXY is trading above its 50-day SMA after a 22.5% rally, fueled by Permian strength and international assets.

image for news OXY Stock is Trading Above 50-Day SMA: Time to Buy, Hold or Sell?

Here's Why Silver ETFs Are Soaring to New Highs — Positive

SLV   Zacks Investment Research — July 14, 2025

SLV and SIVR surge as silver hits highs not seen since 2011, fueled by tariffs, supply strain and soaring industrial demand.

image for news Here's Why Silver ETFs Are Soaring to New Highs

BALTIMORE--(BUSINESS WIRE)--Sinclair today announced a collaboration with the American Cancer Society (ACS) to launch Sinclair Cares: Help Drive Out Cancer, a nationwide campaign dedicated to raising awareness about the transportation barriers people with cancer face in accessing lifesaving treatment. The campaign spotlights the American Cancer Society Road To Recovery® program, which provides free rides to treatment for those in need, while encouraging volunteerism and financial support. As pa.

image for news Sinclair Launches Sinclair Cares: Help Drive Out Cancer, Joins the American Cancer Society to Raise Awareness and Support Free Rides to Medical Treatment

Autodesk (ADSK) shares surged Monday following a report the company is no longer looking to purchase rival design software maker PTC (PTC).

image for news Autodesk's Stock Climbs Following Report It's No Longer Looking to Buy PTC

Cash Doubles, Losses Widen: Is BigBear.ai Stock Still Worth the Risk? — Negative

BBAI   Zacks Investment Research — July 14, 2025

BigBear.ai Holdings BBAI is navigating a mixed financial picture in early 2025, leaving investors to weigh short-term margin pressure against longer-term strategic flexibility. In its first-quarter 2025 report, the company posted a wider adjusted EBITDA loss of $7 million compared with a $1.6 million loss a year ago.

image for news Cash Doubles, Losses Widen: Is BigBear.ai Stock Still Worth the Risk?

The crypto exchange is on pace to finish with a market capitalization just under $100 billion.

image for news Coinbase Is the Real Trump Trade as Stock Set for Record Closing High

NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Reddit, Inc. (NYSE: RDDT) between October 29, 2024 and May 20, 2025, both dates inclusive (the “Class Period”), of the important August 18, 2025 lead plaintiff deadline.

image for news ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Reddit, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RDDT

PayPal: A 2025 Turnaround Hiding In Plain Sight — Positive

PYPL   Seeking Alpha — July 14, 2025

PayPal Holdings, Inc. is generating billions in free cash flow, expanding margins, and gaining enterprise traction — yet the market still prices it like a dying fintech. With 436 million active users, sticky merchant relationships, and platform-agnostic tech, PayPal's network moat is stronger than analysts give it credit for. New leadership is cutting costs, focusing on high-margin products, and quietly executing a turnaround that could catch Wall Street off guard in 2025.

image for news PayPal: A 2025 Turnaround Hiding In Plain Sight

Mark Zuckerberg says Meta is building a 5GW AI data center — Positive

META   TechCrunch — July 14, 2025

Meta is currently building out a data center, called Hyperion, which the company expects to supply its new AI lab with five gigawatts (GW) of computational power, CEO Mark Zuckerberg said in a Monday post on Threads.

image for news Mark Zuckerberg says Meta is building a 5GW AI data center

Is Pagaya Stock's Low Valuation an Opportunity or a Value Trap? — Positive

PGY   Zacks Investment Research — July 14, 2025

At a glance, Pagaya Technologies PGY stock looks attractively priced in terms of its price/sales (P/S) ratio when compared with its peers. Value investors try to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts compared with fair value.

image for news Is Pagaya Stock's Low Valuation an Opportunity or a Value Trap?

NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS

NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SRPT